HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation? | Journal of Clinical Pathology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via ACP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

PostScript

Letter to the Editor

HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation?

Authors

Cathy B Moelans PubMed articles Google scholar articles
Paul J van Diest PubMed articles Google scholar articles

Correspondence to Cathy B Moelans, Department of Pathology (H04.310), UMC Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands; cmoelans{at}umcutrecht.nl

Citation

Moelans CB, van Diest PJ

HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation?

Journal of Clinical Pathology 2012;65:379.

Publication history

Accepted September 27, 2011
First published October 26, 2011.

Online issue publication

April 18, 2016

Article Versions

Previous version (18 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.